Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 100: 258-265, 2006. First published September 15, 2005; doi:10.1152/japplphysiol.00936.2005
8750-7587/06 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
100/1/258    most recent
00936.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sellman, J. E.
Right arrow Articles by Criswell, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sellman, J. E.
Right arrow Articles by Criswell, D. S.

In vivo inhibition of nitric oxide synthase impairs upregulation of contractile protein mRNA in overloaded plantaris muscle

Jeff E. Sellman, Keith C. DeRuisseau, Jenna L. Betters, Vitor A. Lira, Quinlyn A. Soltow, Joshua T. Selsby, and David S. Criswell

Center for Exercise Science, University of Florida, Gainesville, Florida

Submitted 1 August 2005 ; accepted in final form 14 September 2005

Inhibition of nitric oxide synthase (NOS) activity in vivo impedes hypertrophy in the overloaded rat plantaris. We investigated the mechanism for this effect by examining early events leading to muscle growth following 5 or 12 days of functional overload. Male Sprague-Dawley rats (~350 g) were randomly divided into three treatment groups: control, NG-nitro-L-arginine methyl ester (L-NAME; 90 mg·kg–1·day–1), and 1-(2-trifluoromethyl-phenyl)-imidazole (TRIM; 10 mg·kg–1·day–1). Unilateral removal of synergists induced chronic overload (OL) of the right plantaris. Sham surgery performed on the left hindlimb served as a normally loaded control. L-NAME and TRIM treatments prevented OL-induced skeletal {alpha}-actin and type I (slow) myosin heavy chain mRNA expression at 5 days. Conversely, neither L-NAME nor TRIM affected hepatocyte growth factor or VEGF mRNA responses to OL at 5 days. However, OL induction of IGF-I and mechanogrowth factor mRNA was greater (P < 0.05) in the TRIM group compared with the controls. Furthermore, the phosphorylated-to-total p70 S6 kinase ratio was higher in OL muscle from NOS-inhibited groups, compared with control OL. At 12 days of OL, the cumulative proliferation of plantaris satellite cells was assessed by subcutaneous implantation of time release 5'-bromo-2'-deoxyuridine pellets during the OL-inducing surgeries. Although OL caused a fivefold increase in the number of mitotically active (5'-bromo-2'-deoxyuridine positive) sublaminar nuclei, this was unaffected by concurrent NOS inhibition. Therefore, NOS activity may provide negative feedback control of IGF-I/p70 S6 kinase signaling during muscle growth. Moreover, NOS activity may be involved in transcriptional regulation of skeletal {alpha}-actin and type I (slow) myosin heavy chain during functional overload.

insulin-like growth factor-I; p70 S6 kinase; functional overload; 1-(2-trifluoromethyl-phenyl)-imidazole; NG-nitro-L-arginine methyl ester



Address for reprint requests and other correspondence: D. Criswell, P. O. Box 118206, Center for Exercise Science, Univ. of Florida, Gainesville, FL 32611 (e-mail: dcriswell{at}hhp.ufl.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
J. A. Drenning, V. A. Lira, C. G. Simmons, Q. A. Soltow, J. E. Sellman, and D. S. Criswell
Nitric oxide facilitates NFAT-dependent transcription in mouse myotubes
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1088 - C1095.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.